A strange and confusing audio illusion is leaving people checking their ears, as not everybody will hear the same thing, and you'll only hear the words you're actually reading
Frequency Therapeutics announced it will scrap development of a drug called FX-322 after testing failed to show improvement in speech perception in people with noise-induced sensorineural hearing loss.
An innovative approach to treating hearing loss might be closer to reaching the market after a setback in the approval process, researchers behind the technology at Frequency Therapeutics told UPI.